| abstract |
The present invention relates to a method for the treatment and prevention of ocular diseases and disorders, which methods comprise, optionally and in combination with other therapies, the administration of antagonist A or other pharmaceutically acceptable salts thereof to a subject in need of treatment . The invention also relates to a method for the treatment and prevention of ocular diseases and disorders, which methods comprise, optionally and in combination with other therapies, administering an anti-C5 agonist (such as ARC1905) . |